DOAC After LAAC Beats DAPT Only in Observational Data
Analysis Anticoagulation / Hematology Inconclusive Grade: Low
Alam U, Ahmed AU, Javed J, et al.
Aug 7, 2026 · Published in: Journal of Thrombosis and Thrombolysis
DOACs may outperform DAPT after LAAC in NVAF patients.
Anticoagulation Bests Antiplatelets After Mitral TEER in AF
Analysis Anticoagulation / Hematology Hypothesis-generating Grade: Very Low
Zhu F, Yu Z, He Z
Aug 5, 2026 · Published in: Frontiers in Cardiovascular Medicine
Also in Cardiology
OAC strategies may reduce bleeding risk post-TMVR.
DOAC Dosing in CKD/ESRD: Apixaban Leads, But the Evidence Is Thin
Reference Card Anticoagulation / Hematology
Aug 2, 2026 · Published in: PharmD Signal Reference Card
Also in Nephrology
A pharmacist's guide to DOAC selection, dosing, and the inappropriate dose reduction problem in renal impairment.
Hospital-Wide AF Alert System Boosts Anticoagulation Adherence, Cuts Stroke
Analysis Anticoagulation / Hematology Confirmatory Grade: Low
Liao TW, Chen WT
Jul 29, 2026 · Published in: Acta Cardiologica Sinica
Hospital-wide AF screening enhances anticoagulation guidelines adherence, reduces strokes.
Bayesian Synthesis Finds LAAO Fails Stroke Non-Inferiority Versus Anticoagulation
Analysis Anticoagulation / Hematology Confirmatory Grade: Moderate
Athmakuri KS, Nandyal SR, Pamreddy HR, et al.
Jul 22, 2026 · Published in: Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology
Also in Cardiology
LAAO reduces bleeding but not strokes compared to anticoagulation.
Nurse KAP Survey Reveals Anticoagulant Contraindication Knowledge Gaps
Analysis Anticoagulation / Hematology Hypothesis-generating Grade: Low
Jul 14, 2026 · Published in: Nursing Open
Nurses need better education on anticoagulant contraindications.
Aspirin Monotherapy Noninferior to Rivaroxaban Bridge After Arthroplasty
Analysis Anticoagulation / Hematology Practice-changing Grade: High
Shivakumar S, Matino D, Zukor D, et al.
Jul 12, 2026 · Published in: N Engl J Med
Also in Perioperative / Anesthesia
Aspirin matches rivaroxaban's efficacy in preventing post-surgical blood clots.
Practical Framework for Managing Anticoagulant-Associated Bleeding
Analysis Anticoagulation / Hematology Confirmatory Grade: Low
Galli M, Simeone B, Ten Berg J, et al.
Jul 8, 2026 · Published in: European Heart Journal. Acute Cardiovascular Care
Bleeding risks complicate anticoagulant therapy management in cardiovascular patients.
Factor XIa Inhibitors: Indication-Specific Anticoagulation, Not Broad DOAC Replacement
Analysis Anticoagulation / Hematology Hypothesis-generating Grade: Low
Kidder E, Dhanesha N
Jul 1, 2026 · Published in: Current Opinion in Hematology
Factor XIa inhibitors could transform thrombosis prevention.
LAAC Noninferior to NOAC in Anticoagulation-Eligible AF
Analysis Anticoagulation / Hematology Hypothesis-generating Grade: Moderate
Doshi SK, Kar S, Nair DG, et al.
Jun 4, 2026 · Published in: The New England Journal of Medicine
Also in Cardiology
Atrial appendage closure reduces bleeding in atrial fibrillation.
Catheter Fibrinolysis Cuts Decompensation in Intermediate-Risk PE
Analysis Anticoagulation / Hematology Hypothesis-generating Grade: Moderate
Rosenfield K, Klok FA, Piazza G, et al.
May 28, 2026 · Published in: The New England Journal of Medicine
Combined therapy cuts major events in pulmonary embolism by over half.
Asundexian Cuts Recurrent Stroke Without Excess Bleeding
Analysis Anticoagulation / Hematology Practice-changing Grade: High
Sharma M, Dong Q, Hirano T, et al.
Apr 16, 2026 · Published in: N Engl J Med
Also in Neurology / Neuropharmacology
Added to antiplatelet therapy after noncardioembolic stroke, asundexian lowered recurrent ischemic stroke from 8.4% to 6.2% with no increase in major bleeding.
Factor XI Inhibitors Cut Bleeding but Raise Ischemic Stroke in AF
Analysis Anticoagulation / Hematology Confirmatory Grade: Low
Markides RIL, Koolaji S, Leader JH, et al.
Jun 1, 2025 · Published in: Journal of Thrombosis and Thrombolysis
Factor XI inhibitors reduce bleeding but may affect stroke prevention in atrial fibrillation.
Factor XI Antibody Abelacimab Cuts Bleeding Versus Rivaroxaban in AF
Analysis Anticoagulation / Hematology Hypothesis-generating Grade: Moderate
Ruff CT, Patel SM, Giugliano RP, et al.
Jan 23, 2025 · Published in: New England Journal of Medicine
Abelacimab cuts bleeding risk in atrial fibrillation patients.
OCEANIC-AF: Asundexian Fails Stroke Prevention Versus Apixaban
Analysis Anticoagulation / Hematology Practice-changing Grade: Moderate
Piccini JP, Patel MR, Steffel J, et al.
Jan 2, 2025 · Published in: New England Journal of Medicine
Asundexian falls short on stroke prevention in AFib but cuts bleeding.